| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |